However, conflicting experimental observations on ER stress and CHOP involvement in NAFLD progression based on ER stress suppression [115,116] and CHOP ablation effects [117,118] have yet to be resolved. This evidence concerns the gene DDIT3 and metabolic dysfunction-associated steatotic liver disease.